Evidence map›Paper›PMID 36348341›Full record

ArticleVirology journal2022

Whole-genome sequence analysis reveals the circulation of multiple SARS-CoV-2 variants of concern in Nairobi and neighboring counties, Kenya between March and July 2021.

Samoel Ashimosi Khamadi, Silvanos Opanda, Samwel Lifumo Symekher, Samson Konongoi Limbaso, Solomon Langat, Josyline Kaburi Cirindi, Milkah Mwangi, Nicholas Mwikwabe, Seth Okeyo, Edith Koskei and 11 more

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 1 institution in 1 country.

Samoel Ashimosi KhamadiCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Silvanos OpandaCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Samwel Lifumo SymekherCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Samson Konongoi LimbasoCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Solomon LangatCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Josyline Kaburi CirindiCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Milkah MwangiCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Nicholas MwikwabeCentre for Traditional Medicine and Drug Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Seth OkeyoCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Edith KoskeiCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
James MutisyaCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Samwel OwakaCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Albert NyunjaCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Hellen KokaCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Meshack WadeguCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Esther ChitechiCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Rachel AchillaCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Janet Masitsa MajanjaCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Lucy KanyaraCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya.
Evans AmukoyeCentre for Respiratory Diseases Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Wallace BulimoCentre for Virus Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54628-00200, Nairobi, Kenya. Wbulimo@kemri.org.ORCID 0000-0001-8475-0586
Kenya Medical Research Institute · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence and rapid spread of SARS-CoV-2 variants of concern (VOC) have been linked to new waves of COVID-19 epidemics occurring in different regions of the world. The VOC have acquired adaptive mutations that have enhanced virus transmissibility, increased virulence, and reduced response to neutralizing antibodies. Kenya has experienced six waves of COVID-19 epidemics. In this study, we analyzed 64 genome sequences of SARS-CoV-2 strains that circulated in Nairobi and neighboring counties, Kenya between March 2021 and July 2021. Viral RNA was extracted from RT-PCR confirmed COVID-19 cases, followed by sequencing using the ARTIC network protocol and Oxford Nanopore Technologies. Analysis of the sequence data was performed using different bioinformatics methods. Our analyses revealed that during the study period, three SARS-CoV-2 variants of concern (VOC) circulated in Nairobi and nearby counties in Kenya. The Alpha (B.1.1.7) lineage predominated (62.7%), followed by Delta (B.1.617.2, 35.8%) and Beta (B.1.351, 1.5%). Notably, the Alpha (B.1.1.7) VOC were most frequent from March 2021 to May 2021, while the Delta (B.1.617.2) dominated beginning June 2021 through July 2021. Sequence comparisons revealed that all the Kenyan viruses were genetically similar to those that circulated in other regions. Although the majority of Kenyan viruses clustered together in their respective phylogenetic lineages/clades, a significant number were interspersed among foreign strains. Between March and July 2021, our study's findings indicate the prevalence of multiple lineages of SAR-CoV-2 VOC in Nairobi and nearby counties in Kenya. The data suggest that the recent increase in SARS-CoV-2 infection, particularly in Nairobi and Kenya as a whole, is attributable to the introduction and community transmission of SARS-CoV-2 VOC among the populace. In conclusion, the findings provide a snapshot of the SARS-CoV-2 variants that circulated in Kenya during the study period.

Indexed as

COVID-19SARS-CoV-2HumansKenyaPhylogenySequence AnalysisCoronavirusesKenyaLineageSARS-CoV-2

Identifiers

PMID36348341
PMCPMC9640859
OpenAlexW4308595071

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.